Corbevax News: If you have taken Covishield or Covaccine, then you can take Corbevax as a booster dose, the approval of the Center

New Delhi: If you have been vaccinated against Covishield or Covaccine, you can now get the Corbevax vaccine as a booster. Significantly, the government has already approved the Corbavax vaccine for children aged 12-14 years. Here, due to the increasing case of Corona, strictness has also been increased in Delhi. Wearing of masks in public places has been made mandatory in the state.

Covishield, people taking Covaccine can apply a booster dose of Corbevax
The central government on Wednesday approved the administration of a booster dose of ‘Corbevax’ vaccine to people above 18 years of age who have received two doses of the Covishield or Covaccine vaccine. This is going to be the first time in the country that a vaccine other than the first and second dose vaccines has been allowed as a precautionary dose. In a letter sent to the states and union territories, Union Health Secretary Rajesh Secretary has said that all necessary changes have been made in the Kovin portal in connection with taking ‘Corbevax’ by the eligible people for the third dose.

No change in guidelines for Covishield, Covaccine
He said that for those over the age of 18, who have been six months or 26 weeks after receiving the second dose of Covaccine or Covishield, Corbevax will be available as a precautionary dose. Bhushan said, ‘This will allow Corbavax to be used as a second vaccine for Kovid-19 in this age group as a precautionary dose. There is no change in the current guidelines regarding the third dose of Covaccine and Covishield, he added. The Union Health Minister said that this will strengthen India’s fight against Kovid-19.

12-14 year olds are feeling Corbewax
He tweeted, ‘India’s Ministry of Health and Family Welfare proposes Corbevax as a precautionary dose for those over the age of 18 who have received the Covishield or Covaccine vaccine and six months or 26 weeks after their second dose. have passed. This provision will be available from August 12. India’s first indigenous RBD protein subunit ‘Corbevax’ vaccine is currently being administered to children in the age group of 12 to 14 years.

GCGI approved on 4th June

The COVID-19 Working Group had reviewed the data for the third phase in a meeting held on July 20. It assessed the potential effect on immunity after the third dose of Corbevax vaccine was given to people aged 18 to 80 years who had received two doses of Covishield or Covaccine. Significantly, the Drug Controller General of India (GCGI) on June 4 allowed people 18 years of age and above to get the Corbevax vaccine as a third dose.

Leave a Comment